9-(2-hydroxy-3-nonyl)adenine and paclitaxel

9-(2-hydroxy-3-nonyl)adenine has been researched along with paclitaxel in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kristensson, K; Lycke, E; Röyttä, M; Svennerholm, B; Vahlne, A1
Boons, GJ; Hasko, G; Leibovich, SJ; Pinhal-Enfield, G; Ramanathan, M; Salzman, AL; Vogel, SN1

Other Studies

2 other study(ies) available for 9-(2-hydroxy-3-nonyl)adenine and paclitaxel

ArticleYear
Neuritic transport of herpes simplex virus in rat sensory neurons in vitro. Effects of substances interacting with microtubular function and axonal flow [nocodazole, taxol and erythro-9-3-(2-hydroxynonyl)adenine].
    The Journal of general virology, 1986, Volume: 67 ( Pt 9)

    Topics: Adenine; Alkaloids; Animals; Axonal Transport; Axons; Benzimidazoles; Cells, Cultured; Lectins; Microtubules; Neurons, Afferent; Nocodazole; Paclitaxel; Rats; Simplexvirus; Virus Replication; Wheat Germ Agglutinins

1986
An angiogenic switch in macrophages involving synergy between Toll-like receptors 2, 4, 7, and 9 and adenosine A(2A) receptors.
    The American journal of pathology, 2003, Volume: 163, Issue:2

    Topics: Adenine; Adenosine; Adenosine-5'-(N-ethylcarboxamide); Angiogenesis Inhibitors; Animals; Cells, Cultured; DNA-Binding Proteins; Endothelial Growth Factors; Enzyme Inhibitors; Humans; Intercellular Signaling Peptides and Proteins; Lipopolysaccharides; Lipoproteins; Lymphokines; Macrophages, Peritoneal; Male; Membrane Glycoproteins; Mice; Mice, Inbred C57BL; Mice, Knockout; Neovascularization, Physiologic; NF-kappa B; Paclitaxel; Purinergic P1 Receptor Agonists; Receptor, Adenosine A2A; Receptors, Cell Surface; Receptors, Purinergic P1; Toll-Like Receptor 2; Toll-Like Receptor 3; Toll-Like Receptor 4; Toll-Like Receptor 5; Toll-Like Receptor 7; Toll-Like Receptor 9; Toll-Like Receptors; Tumor Necrosis Factor-alpha; Up-Regulation; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors; Vasodilator Agents

2003